Select language:  
1800 620 420
Close menu

Research in action

All the latest research news and breakthroughs.

Subscribe to hear more from the Leukaemia Foundation.

Familial research key to blood cancer prevention strategy

The Australian Familial Haematological Cancer Study (AFHCS) leads the world in the field and has a research cohort of more than 200 families with a history of blood cancer.

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes
  • Research
Read more
AFHCS research team

PhD scholarships focused on improving outcomes for people with AML and MPN

Basit Salik, Dr Jamie Kuzich and Dr Julian Grabek are the successful recipients of the 2021 PhD Scholarships.

  • Acute myeloid leukaemia
  • Myeloproliferative neoplasms
  • Research
Read more
Illustration of a microscope, test tubes, and clipboard

Drug discovery has remarkable potential for high-risk childhood leukaemia

Dr Michelle Henderson's research is laying the groundwork to develop a promising new therapy for infant ALL.

  • Acute lymphoblastic leukaemia
  • Research
Read more
Dr Michelle Henderson in the lab

From PhD in Melbourne to postdoc in New York

New York-based, Aussie researcher Matt Witkowski has his sights set on improving the effectiveness of CAR T-cell therapy.

  • Acute lymphoblastic leukaemia
  • Research
Read more
Matthew Witkowski

Research aims to improve QOL by decreasing treatment toxicity

Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.

  • Myeloma
  • Research
Read more
Kate van Dyke

Clinical trials critical to finding curative therapies for MPN

Professor David Ross discusses the "massive explosion" of recent clinical trial activity in MPN.

  • Myeloproliferative neoplasms
  • Research
Read more
Dr David Ross and others in Tokyo

Improving outcomes for Australians with an MPN 

Dr Liesl Butler is investigating the gene mutations and biological pathways that lead to the development of MPN.

  • Myeloproliferative neoplasms
  • Research
Read more
Gene

Q&A: Dr Peter Diamond – our head of research

Head of the Leukaemia Foundation’s National Research Program, Dr Peter Diamond discusses his role, priorities for the program, and exciting breakthroughs coming up in blood cancer research. 

  • Research
Read more
Dr Peter Diamond

Searching for “more effective and gentler” therapies for AML

The Professor of Harvard University’s Department of Stem Cell and Regenerative Biology spoke with us about why he chose this line of work, and his research objectives.

  • Acute myeloid leukaemia
  • Research
Read more
Dr David Scadden at a lab meeting at Harvard University

 Adding the microenvironment to the AML therapy mix improves efficacy   

Associate Professor Ingrid Wrinkler's findings have "opened up a whole new field".

  • Acute myeloid leukaemia
  • Research
Read more
Ingrid Winker and Valerie Barbier

Leukaemia Foundation invests almost $3m in innovative AML research

Seven research projects that are part of the National Research Program focus on better understanding and treating acute myeloid leukaemia (AML). 

  • Acute myeloid leukaemia
  • Research
Read more
Dr Laura Bray

Understanding MDS and the biological processes driving treatment response

Dr Steven Lane hopes to understand how myelodysplasia (MDS) forms from normal cells.

  • Myelodysplastic syndromes
  • Research
Read more
Steven Lane in the lab

What’s CAR T-cell therapy?

Dr Bruce Levine explains how it works and why.

  • Research
  • Treatments and side-effects
Read more
Bruce Levine

Q&A: Professor Timothy Hughes – Part 1

We spoke to world leader in CML research, Professor Timothy Hughes.

  • Chronic myeloid leukaemia
  • Research
Read more
Timothy Hughes presenting

Q&A: Professor Timothy Hughes – Part 2

Here is part two of our interview with world leader in CML research, Professor Timothy Hughes.

  • Chronic myeloid leukaemia
  • Research
Read more
Timothy Hughes

“The biggest discoveries come from basic biological research”

Rebecca's research work is looking at different pathways of NK cells in acute myeloid leukaemia.

  • Acute myeloid leukaemia
  • Research
Read more
Rebecca Delconte

Addressing knowledge gaps in immunoglobulin therapy

Dr Khai Li Chai is working to improve the prevention and treatment of infection in blood cancer patients with antibody replacement therapy.

  • Chronic lymphocytic leukaemia
  • Myeloma
  • Non-Hodgkin lymphoma
  • Research
  • Treatments and side-effects
Read more
Khai Li Chai

Better outcomes for aplastic anaemia and bone marrow failure syndromes

Describing, understanding and improving the diagnosis of aplastic anaemia and bone marrow failure syndromes.

  • Blood disorders
  • Research
Read more
Dr Lucy Fox

Multi-Million Dollar Research Program to fight GVHD

There’s an urgent need for new approaches to better prevent and treat GVHD.

  • Research
  • Treatments and side-effects
Read more
Professor David Gottlieb

New research breakthroughs

Researchers such Dr Siok Tey are dedicated to driving rapid advancements in treatments, discovering new therapies, and launching innovative clinical trials.

  • Hodgkin lymphoma
  • Research
Read more
Dr Siok Tey in the lab

Leukaemia Foundation invests in innovative MDS research 

Better understanding and treating MDS is the focus of five new research projects that are part of the Leukaemia Foundation’s National Research Program.

  • Myelodysplastic syndromes
  • Research
Read more
Illustration of a microscope, test tubes, and clipboard

Unlocking the key to understanding cell death 

PhD student Elizabeth is investigating how mutations in a tumour suppressor protein, known as p53, contribute to the development of lymphoma.

  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Research
Read more
Elizabeth Lieschke

Understanding immune system behaviour in blood cancers

Making a difference to the lives of her patients is why Dr Wei Jiang gets up each morning. 

  • Other blood cancers
  • Research
Read more
Dr Wei Jiang

New classifications of MPN mean better diagnostics and more definitive prognoses

How the MPNs are classified is set to change with eight new classifications based on the underlying mechanisms that drive the mutations.

  • Myeloproliferative neoplasms
  • Research
Read more
Professor Tony Green

Preventing different forms of resistance to AML would “make a massive difference”

Leukaemia Foundation Research Fellowship recipient Mark Dawson discusses various areas of AML research.

  • Acute myeloid leukaemia
  • Research
Read more
Blackmores Sydney Running Festival

About the Hovon 150 Trial

The aim of the HOVON 150 trial* is to recruit 968 patients from Europe, Australia and other participating countries.

  • Acute myeloid leukaemia
  • Research
  • Treatments and side-effects
Read more
Illustration of various treatments, pills, medicines

Quest to better understand MDS and find out more effective therapies

When someone with MDS is treated with azacitidine (Vidaza®), it takes six months to find out if they are responding to the drug. Dr Unnikrishnan is working to change that.

  • Myelodysplastic syndromes
  • Research
Read more
Dr Ashwin Unnikrishnan

Talking lymphoma with Associate Professor Jake Shortt

Assoc. Prof. Shortt talks about his work in non-Hodgkin lymphoma research.

  • Non-Hodgkin lymphoma
  • Research
Read more
Jake Shortt

Developing new treatments for Burkitt’s lymphoma

Dr Gemma Kelly is investigating a new anti-cancer drug to treat Burkitt's lymphoma.

  • Non-Hodgkin lymphoma
  • Research
Read more
Dr Gemma Kelly standing in a research lab

Searching for biomarkers and better treatments for B-cell lymphomas

Professor Ricky Johnstone hopes to find new research treatments for B-cell lymphomas.

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms
Read more
Dr Pilar Dominguez with Professor Ricky Johnstone